This company listing is no longer active
Atreca Gestione
Gestione criteri di controllo 3/4
Atreca's CEO is John Orwin, appointed in Apr 2018, has a tenure of 6.17 years. total yearly compensation is $927.03K, comprised of 64.8% salary and 35.2% bonuses, including company stock and options. directly owns 0.2% of the company’s shares, worth €3.37K. The average tenure of the management team and the board of directors is 5 years and 5.5 years respectively.
Informazioni chiave
John Orwin
Amministratore delegato
US$927.0k
Compenso totale
| Percentuale dello stipendio del CEO | 64.8% |
| Mandato del CEO | 6.2yrs |
| Proprietà del CEO | 0.2% |
| Durata media del management | 5yrs |
| Durata media del Consiglio di amministrazione | 5.5yrs |
Aggiornamenti recenti sulla gestione
Recent updates
Analisi delle retribuzioni degli amministratori delegati
| Data | Compenso totale | Stipendio | Guadagni aziendali |
|---|---|---|---|
| Sep 30 2023 | n/a | n/a | -US$98m |
| Jun 30 2023 | n/a | n/a | -US$85m |
| Mar 31 2023 | n/a | n/a | -US$93m |
| Dec 31 2022 | US$927k | US$601k | -US$97m |
| Sep 30 2022 | n/a | n/a | -US$105m |
| Jun 30 2022 | n/a | n/a | -US$110m |
| Mar 31 2022 | n/a | n/a | -US$108m |
| Dec 31 2021 | US$4m | US$583k | -US$109m |
| Sep 30 2021 | n/a | n/a | -US$103m |
| Jun 30 2021 | n/a | n/a | -US$98m |
| Mar 31 2021 | n/a | n/a | -US$92m |
| Dec 31 2020 | US$5m | US$567k | -US$86m |
| Sep 30 2020 | n/a | n/a | -US$83m |
| Jun 30 2020 | n/a | n/a | -US$76m |
| Mar 31 2020 | n/a | n/a | -US$74m |
| Dec 31 2019 | US$845k | US$507k | -US$67m |
| Sep 30 2019 | n/a | n/a | -US$59m |
| Jun 30 2019 | n/a | n/a | -US$53m |
| Mar 31 2019 | n/a | n/a | -US$44m |
| Dec 31 2018 | US$5m | US$319k | -US$38m |
Compensazione vs Mercato: John's total compensation ($USD927.03K) is above average for companies of similar size in the German market ($USD434.04K).
Compensazione vs guadagni: John's compensation has been consistent with company performance over the past year.
AMMINISTRATORE DELEGATO
John Orwin (59 yo)
6.2yrs
Mandato
US$927,033
Compensazione
Mr. John A. Orwin, M.B.A. serves as Chairman of the Board for Nested Therapeutics since February 2024. He serves as Independent Chairman of the Board of AnaptysBio, Inc. since September 15, 2023. He has be...
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| President | 6.2yrs | US$927.03k | 0.20% € 3.4k | |
| Founder & Director | no data | US$665.50k | 0.81% € 14.0k | |
| Principal Accounting Officer | less than a year | Nessun dato | Nessun dato | |
| General Counsel & Corporate Secretary | 5yrs | Nessun dato | 0.073% € 1.3k | |
| Vice President of Finance | no data | Nessun dato | 0.067% € 1.2k |
5.0yrs
Durata media
59.5yo
Età media
Gestione esperta: 0C1's management team is seasoned and experienced (5 years average tenure).
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| President | 6.2yrs | US$927.03k | 0.20% € 3.4k | |
| Founder & Director | 14.4yrs | US$665.50k | 0.81% € 14.0k | |
| Independent Chairman of the Board | 10.5yrs | US$97.77k | 0.13% € 2.2k | |
| Chairman of External Scientific Advisory Board & Technical Advisor | 4.8yrs | US$150.00k | Nessun dato | |
| Independent Director | 4.1yrs | US$64.27k | 0% € 0 | |
| Director | 13.4yrs | US$312.77k | 0.93% € 16.0k | |
| Independent Director | 8.1yrs | US$70.77k | 0% € 0 | |
| Independent Director | 2.9yrs | US$60.27k | 0% € 0 | |
| Board Observer | no data | Nessun dato | Nessun dato | |
| Board Observer | no data | Nessun dato | Nessun dato | |
| Independent Director | 4.8yrs | US$62.77k | 0% € 0 | |
| Independent Director | 2.9yrs | US$57.77k | 0% € 0 |
5.5yrs
Durata media
57.5yo
Età media
Consiglio di amministrazione esperto: 0C1's board of directors are considered experienced (5.5 years average tenure).